|
⚲
|
| Keyboard |
| Stants Kristen
✚
|
|
|---|---|
| CIK # | 0001805727 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001805727] | |
| 4 | [0001805727] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Stants Kristen | |
| Dianthus Therapeutics Inc /DE/ |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Dianthus Therapeutics Inc /DE/ MGTA
Common Stock
|
2022-11-30 | Grant | 3,000 | $0.94 | 2,820 |
|
Dianthus Therapeutics Inc /DE/ MGTA
Stock Option (Right to Buy) · derivative
|
2022-08-01 | Grant | 85,000 | $0.00 | |
|
Dianthus Therapeutics Inc /DE/ MGTA
Common Stock
|
2022-05-31 | Grant | 3,000 | $0.99 | 2,970 |
|
Dianthus Therapeutics Inc /DE/ MGTA
Stock Option (Right to Buy) · derivative
|
2022-05-17 | Grant | 50,000 | $0.00 | |
|
Dianthus Therapeutics Inc /DE/ MGTA
Stock Option (Right to Buy) · derivative
|
2022-02-15 | Grant | 85,000 | $0.00 | |
|
Dianthus Therapeutics Inc /DE/ MGTA
Common Stock
|
2021-09-16 | Sell | 5,736 | $6.73 | 38,603 |
|
Dianthus Therapeutics Inc /DE/ MGTA
Common Stock
|
2021-09-14 | Grant | 20,000 | $0.00 | |
|
Dianthus Therapeutics Inc /DE/ MGTA
Stock Option (Right to Buy) · derivative
|
2021-08-02 | Grant | 67,500 | $0.00 | |
|
Dianthus Therapeutics Inc /DE/ MGTA
Stock Option (Right to Buy) · derivative
|
2021-02-11 | Grant | 67,500 | $0.00 |